TY - JOUR
T1 - Functional human podocytes generated in organoids from amniotic fluid stem cells
AU - Xinaris, Christodoulos
AU - Benedetti, Valentina
AU - Novelli, Rubina
AU - Abbate, Mauro
AU - Rizzo, Paola
AU - Conti, Sara
AU - Tomasoni, Susanna
AU - Corna, Daniela
AU - Pozzobon, Michela
AU - Cavallotti, Daniela
AU - Yokoo, Takashi
AU - Morigi, Marina
AU - Benigni, Ariela
AU - Remuzzi, Giuseppe
N1 - Publisher Copyright:
Copyright © 2016 by the American Society of Nephrology.
PY - 2016/5
Y1 - 2016/5
N2 - Generating kidney organoids using human stem cells could offer promising prospects for research and therapeutic purposes.However, no cell-based strategy has generated nephrons displaying an intact threedimensional epithelial filtering barrier. Here, we generated organoids using murine embryonic kidney cells, and documented that these tissues recapitulated the complex three-dimensional filtering structure of glomerular slits in vivo and accomplished selective glomerular filtration and tubular reabsorption. Exploiting this technology, we mixed human amniotic fluid stem cells with mouse embryonic kidney cells to establish three-dimensional chimeric organoids that engrafted in vivo and grew to form vascularized glomeruli and tubular structures. Human cells contributed to the formation of glomerular structures, differentiated into podocytes with slit diaphragms, and internalized exogenously infused BSA, thus attaining in vivo degrees of specialization and function unprecedented for donor stem cells. In conclusion, human amniotic fluid stem cell chimeric organoids may offer new paths for studying renal development and human podocyte disease, and for facilitating drug discovery and translational research.
AB - Generating kidney organoids using human stem cells could offer promising prospects for research and therapeutic purposes.However, no cell-based strategy has generated nephrons displaying an intact threedimensional epithelial filtering barrier. Here, we generated organoids using murine embryonic kidney cells, and documented that these tissues recapitulated the complex three-dimensional filtering structure of glomerular slits in vivo and accomplished selective glomerular filtration and tubular reabsorption. Exploiting this technology, we mixed human amniotic fluid stem cells with mouse embryonic kidney cells to establish three-dimensional chimeric organoids that engrafted in vivo and grew to form vascularized glomeruli and tubular structures. Human cells contributed to the formation of glomerular structures, differentiated into podocytes with slit diaphragms, and internalized exogenously infused BSA, thus attaining in vivo degrees of specialization and function unprecedented for donor stem cells. In conclusion, human amniotic fluid stem cell chimeric organoids may offer new paths for studying renal development and human podocyte disease, and for facilitating drug discovery and translational research.
UR - https://www.scopus.com/pages/publications/85013694525
U2 - 10.1681/ASN.2015030316
DO - 10.1681/ASN.2015030316
M3 - Article
C2 - 26516208
AN - SCOPUS:85013694525
SN - 1046-6673
VL - 27
SP - 1400
EP - 1411
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 5
ER -